HZ
Huda Y Zoghbi (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $7.2M of REGN (7,439 sh across 2 lots, as filed), executed Nov 3. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.0M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$7.2M7,439 sh across 2 lots
Exec Nov 3
Filed Nov 5 · 4:05 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $640K
800 sh × $800.00
Exec Aug 10
Filed Aug 12 · 4:14 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $1.1M
1,426 sh across 6 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET